Consensus Conference on Intracranial Atherosclerotic Disease: Rationale, Methodology, and Results: Views and Reviews

Journal of Neuroimaging

Volumn 19, Issue SUPPL. 1, 2009, Pages

  Qureshi, Adnan I ^a   Feldmann, Edward ^b   Gomez, Camilo R ^c   Johnston, S Claiborne ^d   Kasner, Scott E ^e   Quick, Donald C ^a   Rasmussen, Peter A ^f   Suri, M Fareed K ^a   Taylor, Robert A ^a   Zaidat, Osama O ^g  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BROWN UNIVERSITY   (United States)

^c Alabama Neurological Institute   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Angioplasty; Conference; Consensus; Delphi method; Intracranial atherosclerosis; Intracranial stenosis; Stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; HIRULOG; LOTRAFIBAN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLACEBO; WARFARIN;

AFRICAN AMERICAN; ANGIOPLASTY; ANTICOAGULANT THERAPY; ASIAN; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED RELEASE FORMULATION; CORONARY ARTERY ATHEROSCLEROSIS; HIGH RISK POPULATION; HISPANIC; HUMAN; NONHUMAN; PRACTICE GUIDELINE; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE;

HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; RISK FACTORS; THROMBOEMBOLISM;

EID: 70350503358     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00414.x     Document Type: Conference Paper

References (37)

1. Qureshi AI, Ziai WC, Yahia AM, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery 2003 52 : 1033 1039 discussion 1039-1040.
2. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996 27 : 1974 1980.
3. Bang OY, Lee PH, Yoon SR, et al. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 2005 76 : 1128 1134.
4. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000 55 : 490 497.
5. Yoon BW, Bae HJ, Kang DW, et al. Intracranial cerebral artery disease as a risk factor for central nervous system complications of coronary artery bypass graft surgery. Stroke 2001 32 : 94 99.
6. Feldmann E, Wilterdink JL, Kosinski A, et al., Neuroimaging of Intracranial Atherosclerosis Trial I. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. [see comment]. Neurology 2007 68 : 2099 2106.
7. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006 66 : 1187 1191.
8. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 352 : 1305 1316.
9. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006 113 : 555 563.
10. Turan TN, Cotsonis G, Lynn MJ, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007 115 : 2969 2975.
11. Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007 69 : 2063 2068.
12. Kasner SE, Lynn MJ, Chimowitz MI, et al., Warfarin Aspirin Symptomatic Intracranial Disease Trial I. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006 67 : 1275 1278.
13. Ovbiagele B, Lynn MJ, Saver JL, et al. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis 2007 24 : 283 288.
14. Kasner SE, Lynn MJ, Jackson BP, et al., Warfarin Versus Aspirin for Symptomatic Intracranial Disease Trial I. Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis 2007 16 : 216 219.
15. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005 36 : 782 786.
16. Harrington RA, Armstrong PW, Graffagnino C, et al. Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease. Circulation 2000 102 : 728 735.
17. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007 38 : 1531 1537.
18. Jiang WJ, Xu XT, Jin M, et al. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR 2007 28 : 830 834. (Pubitemid 46776056)
19. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007 38 : 881 887.
20. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008 70 : 1518 1524.
21. Kurre W, Berkefeld J, Sitzer M, et al. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 2008 50 : 701 708.
22. Siddiq F, Vazquez G, Memon MZ, et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008 39 : 2505 2510.
23. Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 2007 6 : 407 413.
24. SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004 35 : 1388 1392.
25. Qureshi AI, Alexandrov AV, Tegeler CH, et al. Guidelines for screening of extracranial carotid artery disease: a statement for healthcare professionals from the multidisciplinary practice guidelines committee of the American Society of Neuroimaging; cosponsored by the Society of Vascular and Interventional Neurology. J Neuroimaging 2007 17 : 19 47.
26. Qureshi AI, Janardhan V, Hanel RA, et al. Comparison of endovascular and surgical treatments for intracranial aneurysms: an evidence-based review. Lancet Neurol 2007 6 : 816 825.
27. -42 CFR 50, subpart F. Responsibility of applicants for promoting objectivity in research for which PHS funding is sought. Washington, DC: Department of Health and Human Services, 2000.
28. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002 346 : 1901 1902.
29. Fink A, Kosecoff J, Chassin M, et al. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984 74 : 979 983.
30. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995 311 : 376 380.
31. Perry S, Kalberer JT Jr. The NIH consensus-development program and the assessment of health-care technologies: the first two years. N Engl J Med 1980 303 : 169 172.
32. Bowles N. The Delphi technique. Nurs Stand 1999 13 : 32 36.
33. Goodman CM. The Delphi technique: a critique. J Adv Nurs 1987 12 : 729 734.
34. Keeney S, Hasson F, McKenna HP. A critical review of the Delphi technique as a research methodology for nursing. Int J Nurs Stud 2001 38 : 195 200.
35. Qureshi AI, Suri MFK, Nasar A, et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke 2007 38 : 2180 2184.
36. Krumholz HM, Peterson ED, Ayanian JZ, et al., National Heart LaBIwg. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005 111 : 3158 3166.
37. Krumholz HM, Brindis RG, Brush JE, et al., American Heart A, Quality of Care and Outcomes Research Interdisciplinary Writing G, Council on Epidemiology and P, Stroke C, American College of Cardiology F. Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 2006 113 : 456 462.